Kiaro Holdings Corp. operates in the medical pharmaceuticals sector, focusing on the production and distribution of cannabis-based products primarily in Canada. The company aims to leverage its established supply chain and regulatory expertise to capture market share in the rapidly growing cannabis market, which is projected to expand significantly as regulations evolve.
HealthcareMedical - Pharmaceuticalsmoderate - The company has variable costs associated with production and distribution, but benefits from economies of scale as it increases production volumes.